Medical News

RSS

Eisai's NDA for Aricept tablets for treatment of Alzheimer's disease accepted for review

Eisai Inc. and Pfizer Inc announced today that the U.S. Food and Drug Administration (FDA) has accepted for review Eisai's New Drug Application (NDA) for once daily 23 mg Aricept® (donepezil HCl extended release) tablets for the treatment of moderate to severe Alzheimer's disease (AD).

25 Nov 2009

Springer and ACMT collaborate to publish ‘Journal of Medical Toxicology’

Springer and the American College of Medical Toxicology (ACMT) have signed an agreement to collaborate on the publication of the Journal of Medical Toxicology (JMT), the official journal of the ACMT, beginning in March 2010. It was previously published by the University of Pennsylvania Press.

25 Nov 2009

AssistMed implements InterSystems Ensemble rapid integration and development platform for its EHR system

InterSystems Corporation today announced that AssistMed, Inc. has chosen the InterSystems Ensemble® rapid integration and development platform to provide integration capability for its AssistMed EHR.

25 Nov 2009

Bioniche Life Sciences announces the issuance of MCC patents in Japan

Bioniche Life Sciences Inc., a research-based, technology-driven Canadian biopharmaceutical company, today announced the issuance of a number of patents in Japan for its proprietary Mycobacterial Cell Wall-DNA Complex (MCC) composition.

25 Nov 2009

Positive efficacy data from Phase 2 study of AEZS-108 announced

AEterna Zentaris Inc. (the "Company"), a global biopharmaceutical company focused on endocrine therapy and oncology, today announced positive efficacy data from a Phase 2 study with its targeted cytotoxic peptide conjugate, AEZS-108 (formerly AN-152), in patients with advanced or recurrent endometrial cancer.

25 Nov 2009

CXCL5 molecule causes insulin resistance and type 2 diabetes in obese people

Many people who are overweight or obese develop insulin resistance and type 2 diabetes at some stage in their lives. A European research team has now discovered that obese people have large amounts of the molecule CXCL5, produced by certain cells in fatty tissue.

25 Nov 2009

Pharmaceutical Institute introduces comprehensive series of e-courses on hospital marketplace

Pharmaceutical Institute, a leading provider of specialized training solutions for the pharmaceutical and biotech industry, today announced the launch of a new e-course titled, Hospital Marketplace. The new Hospital Marketplace e-course is the newest addition to the company's Managed Markets Excellence(TM) series, a comprehensive series of e-courses designed to fill the critical need for basic and advanced managed markets knowledge for commercial professionals.

25 Nov 2009

New biodegradable drug-eluting fibers advance stent technology and brain surgery

Stents that keep weakened and flabby arteries from collapsing have been true life-savers. But after six months, those stents are no longer needed -- once the arteries are strengthened, they become unnecessary. Previously, doctors had no choice but to leave them in place.

25 Nov 2009

Wellcore announces leadership team and product introduction plans

Wellcore Corporation, a Silicon Valley-based company dedicated to developing wireless products and services that promote wellness, safety and security, is announcing its leadership team and product introduction plans.

25 Nov 2009

Faulty enzyme may contribute to malignant brain tumour formation

Around 70 per cent of people with a type of brain tumour - called a low-grade glioma - have a faulty version of an enzyme called IDH1. The mutation is also found in a significant proportion of patients with acute myeloid leukaemia.

25 Nov 2009

New online vision therapy program from Infinite Mind

Infinite Mind, a Salt Lake City based software company, announces the launch of a new online vision therapy program eyeQ, the software program is to be used in conjunction with existing in-office therapy methods.

25 Nov 2009

Comparison study finds no significant differences in post-transplant survival rates of NASH and ETOH groups

Researchers at the University of Miami School of Medicine compared the outcomes of cirrhotic patients who underwent liver transplants for nonalcoholic steatohepatitis (NASH) versus alcoholic liver disease (ETOH) and found no statistically significant differences in post-transplant survival rates between the NASH and ETOH groups

25 Nov 2009

New findings suggest current system of classifying psychoactive drugs in UK may need to be revisited

Drug users are well informed about the harms associated with the drugs they use, and perceive alcohol and tobacco to be amongst the most dangerous substances, according to a survey by UCL (University College London) and Imperial College London researchers.

25 Nov 2009

HAMS: A support and informational program to deal with alcohol problems

There is a new game in town when it comes to dealing with alcohol problems. It is harm reduction, offering pragmatic and realistic strategies where traditional approaches to alcohol problems have failed. Spearheading this movement is a group called HAMS -- Harm Reduction, Alcohol Abstinence and Moderation Support. HAMS is a free-of-charge, lay-led support and informational group for people who drink alcohol.

25 Nov 2009

Guardian Life Insurance Company of America continues its present coverage guidelines for mammography screenings

The Guardian Life Insurance Company of America (Guardian), one of the largest mutual life insurers and a leading provider of employee benefits for small and mid-sized companies, today announced that the company will continue to follow its current insurance coverage guidelines for mammography screenings.

25 Nov 2009

Medical News

Eisai's NDA for Aricept tablets for treatment of Alzheimer's disease accepted for review

Springer and ACMT collaborate to publish ‘Journal of Medical Toxicology’

AssistMed implements InterSystems Ensemble rapid integration and development platform for its EHR system

Bioniche Life Sciences announces the issuance of MCC patents in Japan

Positive efficacy data from Phase 2 study of AEZS-108 announced

CXCL5 molecule causes insulin resistance and type 2 diabetes in obese people

Pharmaceutical Institute introduces comprehensive series of e-courses on hospital marketplace

New biodegradable drug-eluting fibers advance stent technology and brain surgery

Wellcore announces leadership team and product introduction plans

Faulty enzyme may contribute to malignant brain tumour formation

New online vision therapy program from Infinite Mind

Comparison study finds no significant differences in post-transplant survival rates of NASH and ETOH groups

New findings suggest current system of classifying psychoactive drugs in UK may need to be revisited

HAMS: A support and informational program to deal with alcohol problems

Guardian Life Insurance Company of America continues its present coverage guidelines for mammography screenings

Involving family members in medical rounds can improve standard of care, says new study

High salt intake poses greater risk for stroke and cardiovascular disease

People with severe EBS at increased risk of skin cancer, say scientists

Strategies to elicit response in autistic children

$80 million grants may soon be available to support health information technology workforce

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Shaping the future of lab automation through AI and robotics

Latest News